P&G Hygiene and Health Care logo

P&G Hygiene and Health Care

PGHH NSE

Key Fundamentals

SmallcapPersonal CareConsumer Goods
Market Cap
₹21,846 Cr
Volatility
Low Risk
P/E Ratio
27.25
EBITDA
₹1,214 Cr
Return on Equity
113.67%
Debt to Equity
0
Book Value
₹232.12
EPS
₹229.57
52W High
₹14,509
52W Low
₹6,782

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

5
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is providing a good dividend yield of 3.46%.
  • Company has a good return on equity (ROE) track record: 3 Years ROE 89.3%
  • Company has been maintaining a healthy dividend payout of 91.5%

Weaknesses

2
  • Stock is trading at 28.6 times its book value
  • The company has delivered a poor sales growth of 7.40% over past five years.

Growth Rate

Revenue Growth
27% higher than 3Y
Net Income Growth
34.54% higher than 3Y
Cash Flow Change
54.48% lower than 3Y
ROE
31.59% lower than 3Y
ROCE
31.92% higher than 3Y
EBITDA Margin (Avg.)
5.18% lower than 3Y

AI Analysis — Bull vs Bear

2d ago
AI opinion · based on fundamentals
Risk medium

Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of about ₹22,314 Cr and trades at 28.2x earnings and 29.6x book value. Its capital efficiency is very high: ROE was 115% last year and averaged 89% over 3 years, it has almost no debt, and it pays out 91.5% of profits for a dividend yield of about 3.4% to 3.7%. On the other side, sales have grown only 3% a year over 3 years, TTM sales are down 2% and TTM profit is down 5%, and the stock has returned -51% over 1 year and 0% a year over 10 years.

Bull Case 7
  • Capital efficiency is very high. ROE was 115% last year, 89% over 3 years and 83% over 5 years, so the business earns large returns on the equity it uses.
  • ROE has risen over time, from a 10-year average of 60% to 83% over 5 years, 89% over 3 years and 115% last year.
  • The company is almost debt free and has reduced its debt. This lowers financial risk and interest costs.
  • The dividend yield is 3.71% (3.35% on the pros-list figure), backed by a 91.5% payout ratio. That is a large share of profits returned to shareholders.
  • Profit has grown faster than sales. Profit compounded at 14% a year over both 3 and 5 years, while sales grew 3% and 7%, which suggests better margins and cost control.
  • The stock is down 51% over 1 year. The current P/E of 28.2x reflects a large price correction, which lowers the valuation starting point compared with before.
  • Profit has compounded at 9% a year over 10 years, showing steady long-term earnings growth despite recent weakness.
Bear Case 7
  • The stock has done poorly for shareholders. Price CAGR is -51% over 1 year, -27% over 3 years, -13% over 5 years and 0% over 10 years.
  • Recent results are shrinking. TTM sales are down 2% and TTM profit is down 5%, compared with 14% annual profit growth over 3 years.
  • Revenue growth is slow. Sales compounded at only 3% a year over 3 years, 7% over 5 years and 6% over 10 years, which is modest for a consumer goods company.
  • The stock trades at 29.6x book value. Some of this reflects the high ROE and the large dividend payouts that keep book value small, but it is still a steep premium to net assets.
  • A P/E of 28.2x comes with -5% TTM profit growth and 3% 3-year sales growth. On a growth-adjusted basis the valuation is not obviously cheap.
  • Most of the recent profit growth came from margins, with 14% profit CAGR against 3% sales CAGR over 3 years. Margins cannot keep expanding forever, so future profit growth will depend more on sales, which are currently falling (-2% TTM).
  • With 91.5% of profits paid out, little is kept for reinvestment. The dividend also depends directly on earnings, which fell 5% on a TTM basis.

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

1d ago
Headwinds 1
  • Flat FY26 topline growth Sep 8

    P&G Hygiene and Health Care reported flat sales for FY26, which means demand did not grow. Profit growth relied on margin and cost levers rather than volume or price.

Positives 1
  • FY26 PAT up 19% Sep 8

    PAT rose 19% in FY26 even though sales were flat, helped by INR 86 crore in productivity savings. At the AGM, management also set out an integrated growth strategy to restart topline growth.

Neutral 1
  • Delisting rumours denied as baseless Sep 23

    The company called rumours of a possible delisting or winding up of operations baseless. It also restated its commitment to being transparent with stakeholders.

TL;DR: PGHH is running its business efficiently: PAT grew 19% in FY26, driven by INR 86 crore in productivity savings. The main risk is flat sales, because cost savings alone cannot drive earnings growth for long. The company's denial of delisting and winding-up rumours on Sep 23 should ease uncertainty about its future. The outlook depends on whether the new integrated growth strategy can turn margin gains into volume-led revenue growth in the coming quarters.

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
853
1,138
1,133
1,002
932
1,135
1,248
992
937
1,150
1,262
941
891
Expenses
638
853
824
745
813
845
877
782
671
865
860
723
721
Operating Profit
215
285
310
257
118
290
371
210
266
285
402
218
170
OPM %
25%
25%
27%
26%
13%
26%
30%
21%
28%
25%
32%
23%
19%
Other Income
10
16
16
14
7
8
10
19
8
10
12
12
9
Interest
3
2
3
22
0
2
7
6
0
4
3
3
0
Depreciation
15
14
14
15
13
12
10
10
9
9
10
10
10
PBT
207
284
309
234
112
285
364
213
265
282
402
218
170
Tax %
27%
26%
26%
34%
28%
26%
26%
27%
27%
26%
25%
30%
26%
Net Profit
151
211
229
154
81
212
269
156
192
210
301
153
126
EPS in Rs
46.59
64.91
70.52
47.56
24.97
65.28
82.74
48.09
59.17
64.65
92.87
47.17
38.9
Figures in ₹ Crores

Profit & Loss

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026TTM
Sales
2,334
2,275
2,320
2,455
2,947
3,002
3,574
3,901
3,918
4,206
3,374
4,290
4,245
Expenses
1,838
1,667
1,646
1,834
2,329
2,396
2,688
3,069
3,048
3,230
2,503
3,119
3,170
Operating Profit
495
608
675
622
618
606
886
832
869
976
871
1,171
1,075
OPM %
21%
27%
29%
25%
21%
20%
25%
21%
22%
23%
26%
27%
25%
Other Income
64
85
67
18
45
42
38
23
40
47
37
42
44
Interest
6
6
10
5
5
6
6
11
11
27
14
9
10
Depreciation
53
52
60
52
50
48
48
53
58
56
32
37
38
PBT
501
636
672
582
607
594
870
790
839
939
862
1,167
1,072
Tax %
31%
34%
36%
36%
31%
27%
25%
27%
19%
28%
26%
27%
—
Net Profit
346
422
433
375
419
433
652
576
678
675
637
856
791
EPS in Rs
107
130
133
115
129
133
201
177
209
208
196
264
244
Div. Payout %
28%
28%
292%
35%
68%
79%
157%
90%
89%
123%
89%
97%
—
Figures in ₹ Crores

Balance Sheet

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Equity Capital
32
32
32
32
32
32
32
32
32
32
32
32
Reserves
1,196
1,619
494
773
877
1,125
682
705
914
742
705
721
Borrowings
0
0
0
0
0
0
3
5
4
3
2
1
Other Liabilities
719
515
634
620
708
671
915
940
1,187
1,081
1,015
1,049
Total Liabilities
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Fixed Assets
309
317
286
250
234
206
184
164
170
139
131
163
CWIP
39
35
41
21
15
22
38
44
23
28
41
21
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
1,600
1,814
834
1,154
1,368
1,600
1,411
1,475
1,945
1,692
1,583
1,619
Total Assets
1,948
2,166
1,160
1,425
1,617
1,828
1,633
1,683
2,137
1,859
1,755
1,804
Figures in ₹ Crores

Cash Flow

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Operating
426
352
445
415
413
474
863
573
826
470
598
924
Investing
28
221
149
-19
34
75
7
-27
-10
1
-34
11
Financing
-105
-122
-1,559
-106
-314
-190
-1,106
-569
-477
-861
-671
-845
Net Cash Flow
349
452
-964
290
134
358
-236
-23
339
-390
-107
91
Free Cash Flow
348
300
401
377
410
423
832
523
781
427
544
893
CFO/OP
127
91
103
111
105
102
126
99
121
79
96
105
Figures in ₹ Crores

Ratios

Particulars Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024Mar 2025Mar 2026
Debtor Days
18
24
21
22
22
20
15
18
20
21
33
21
Inventory Days
47
53
71
48
60
68
78
55
48
51
64
51
Days Payable
148
134
145
156
162
175
237
183
213
193
235
197
Cash Conversion Cycle
-83
-57
-53
-87
-79
-87
-144
-110
-145
-121
-138
-126
Working Capital Days
4
8
-15
-23
-12
-21
-39
-34
-53
-32
-30
-31
ROCE %
46%
45%
64%
89%
73%
58%
94%
110%
101%
112%
104%
157%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view P&G Hygiene and Health Care insights

63 extracted metrics + investor summaries across FY10–FY27.

Log in — free

Shareholding Pattern

FIIs0.98%Promot.70.64%Others2.76%Public10.04%DIIs15.59%As ofJun 2026

Documents

Frequently Asked Questions about P&G Hygiene and Health Care

What does Procter & Gamble Hygiene and Health Care Ltd do?
Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care bran...
Where is Procter & Gamble Hygiene and Health Care Ltd (PGHH) listed?
Procter & Gamble Hygiene and Health Care Ltd trades as PGHH on the NSE and under code 500459 on the BSE.
Which sector does Procter & Gamble Hygiene and Health Care Ltd belong to?
Procter & Gamble Hygiene and Health Care Ltd is classified under the Consumer Goods sector, in the Personal Care industry.
What is the market capitalisation of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd has a market capitalisation of ₹21,846 Cr, which places it in the Large Cap band.
What is the PE ratio of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd trades at a PE ratio of 27.25, on earnings per share of ₹229.57, against a book value of ₹232.12 per share.
What is the 52-week high and low of Procter & Gamble Hygiene and Health Care Ltd?
Over the last 52 weeks Procter & Gamble Hygiene and Health Care Ltd has traded between ₹6,782 and ₹14,509.
Does Procter & Gamble Hygiene and Health Care Ltd pay dividends?
Procter & Gamble Hygiene and Health Care Ltd has a dividend yield of 3.75%.
What is the Return on Equity (ROE) of Procter & Gamble Hygiene and Health Care Ltd?
Procter & Gamble Hygiene and Health Care Ltd reported a return on equity of 113.67%. Its debt-to-equity ratio is 0.00.

Company Information

Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast moving consumer goods in the femcare and healthcare businesses. Its portfolio includes WHISPER – India’s leading Feminine Hygiene brand, and VICKS – India’s No. 1 Health Care brand and Old Spice.

Website pg.com/en_IN
Listed 2004-07-07
Face Value ₹ 10
Issued Size 3,24,60,736

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/PGHH.md for Procter & Gamble Hygiene and Health Care Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Consumer Goods → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List